Baretton G - Search Results

1

Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary gastrointestinal stromal tumors (GISTs).

Kern A, Görgens H, Dittert DD, Krüger S, Richter KK, Schackert HK, Saeger HD, Baretton G, Pistorius S. Kern A, et al. Among authors: baretton g. J Surg Oncol. 2011 Jul 1;104(1):59-65. doi: 10.1002/jso.21905. Epub 2011 Mar 8. J Surg Oncol. 2011. PMID: 21387320

2

Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.

Dittert DD, Kielisch C, Alldinger I, Zietz C, Meyer W, Dobrowolski F, Saeger HD, Baretton GB. Dittert DD, et al. Hum Pathol. 2008 Jul;39(7):1002-10. doi: 10.1016/j.humpath.2007.11.016. Epub 2008 May 20. Hum Pathol. 2008. PMID: 18495213

3

Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer.

Alldinger I, Dittert D, Peiper M, Fusco A, Chiappetta G, Staub E, Lohr M, Jesnowski R, Baretton G, Ockert D, Saeger HD, Grützmann R, Pilarsky C. Alldinger I, et al. Among authors: baretton g. Pancreatology. 2005;5(4-5):370-9. doi: 10.1159/000086537. Epub 2005 Jun 23. Pancreatology. 2005. PMID: 15983444

4

Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme.

Martinez R, Schackert HK, Appelt H, Plaschke J, Baretton G, Schackert G. Martinez R, et al. Among authors: baretton g. J Cancer Res Clin Oncol. 2005 Feb;131(2):87-93. doi: 10.1007/s00432-004-0592-5. Epub 2004 Oct 16. J Cancer Res Clin Oncol. 2005. PMID: 15672285

5

Improved protocol for laser microdissection of human pancreatic islets from surgical specimens.

Sturm D, Marselli L, Ehehalt F, Richter D, Distler M, Kersting S, Grützmann R, Bokvist K, Froguel P, Liechti R, Jörns A, Meda P, Baretton GB, Saeger HD, Schulte AM, Marchetti P, Solimena M. Sturm D, et al. J Vis Exp. 2013 Jan 6;(71):50231. doi: 10.3791/50231. J Vis Exp. 2013. PMID: 23329157 Free PMC article.

6

Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.

Sitek B, Sipos B, Alkatout I, Poschmann G, Stephan C, Schulenborg T, Marcus K, Lüttges J, Dittert DD, Baretton G, Schmiegel W, Hahn SA, Klöppel G, Meyer HE, Stühler K. Sitek B, et al. Among authors: baretton g. J Proteome Res. 2009 Apr;8(4):1647-56. doi: 10.1021/pr800890j. J Proteome Res. 2009. PMID: 19714807

7

Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes.

Solimena M, Schulte AM, Marselli L, Ehehalt F, Richter D, Kleeberg M, Mziaut H, Knoch KP, Parnis J, Bugliani M, Siddiq A, Jörns A, Burdet F, Liechti R, Suleiman M, Margerie D, Syed F, Distler M, Grützmann R, Petretto E, Moreno-Moral A, Wegbrod C, Sönmez A, Pfriem K, Friedrich A, Meinel J, Wollheim CB, Baretton GB, Scharfmann R, Nogoceke E, Bonifacio E, Sturm D, Meyer-Puttlitz B, Boggi U, Saeger HD, Filipponi F, Lesche M, Meda P, Dahl A, Wigger L, Xenarios I, Falchi M, Thorens B, Weitz J, Bokvist K, Lenzen S, Rutter GA, Froguel P, von Bülow M, Ibberson M, Marchetti P. Solimena M, et al. Diabetologia. 2018 Mar;61(3):641-657. doi: 10.1007/s00125-017-4500-3. Epub 2017 Nov 28. Diabetologia. 2018. PMID: 29185012 Free PMC article.

8

Living with severe dysphagia for 10 years: consequence of misdiagnosis.

Krautz C, Ney M, Gastmeier J, Baretton G, Saeger HD, Konopke R. Krautz C, et al. Among authors: baretton g. Scand J Gastroenterol. 2010;45(1):122-3. doi: 10.3109/00365520903348692. Scand J Gastroenterol. 2010. PMID: 19883271 No abstract available.

9

Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.

Jakob C, Liersch T, Meyer W, Baretton GB, Schwabe W, Häusler P, Kulle B, Becker H, Aust DE. Jakob C, et al. Am J Surg Pathol. 2006 Sep;30(9):1169-74. doi: 10.1097/01.pas.0000213302.13435.6e. Am J Surg Pathol. 2006. PMID: 16931962

10

Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?

Kopp R, Diebold J, Dreier I, Cramer C, Glas J, Baretton G, Jauch KW. Kopp R, et al. Among authors: baretton g. Surg Endosc. 2005 Nov;19(11):1507-12. doi: 10.1007/s00464-005-0043-7. Epub 2005 Sep 21. Surg Endosc. 2005. PMID: 16177872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page